Project Grant R01NS143631
Award Date 9/3/26
Completion Date 7/31/31
Dollars Obligated $449K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tallahassee, FL 32306, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded $588,794 to the University of South Florida on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating the functions of microglial laminin in blood-brain barrier repair and microglial activation following ischemic stroke. The research encompasses three aims: examining the function of microglial laminin in stroke...
- The National Institute on Aging awarded Florida State University $664,279 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate extracellular vesicles derived from induced pluripotent stem cell brain organoids as therapeutic targets for Alzheimer's disease. The research combines human iPSC organoid technology, extracellular vesicle engineering, and animal models to examine how tau, amyloid-beta, and extracellular vesicles interact to trigger pathogenic cascades in...
- The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, awarded the University of Pennsylvania $703,249 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, assistance type: Project Grant, award number R01NS141408). The funded work integrates large-scale proteomics and genomics to characterize ischemic stroke risk factors and biological pathways. The research scans 6,432...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pittsburgh $587,678 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to elucidate immune cell trafficking and biodegradation of bioscaffolds implanted in brain tissue using multi-color 19F magnetic resonance imaging. The research visualizes the spatio-temporal dynamics of peripheral immune cell accumulation and invasion into...
- The National Institute of Neurological Disorders and Stroke awarded the University of Wisconsin–Madison $494,240 on February 16, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate target-directed microRNA degradation in post-stroke brain tissue. The project examines how microRNA-7 is depleted following stroke despite intact biogenesis, hypothesizing that target-directed microRNA degradation (TDMD) drives this loss....
- The National Institute of Neurological Disorders and Stroke awarded $574,660 to Icahn School of Medicine at Mount Sinai on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate neutrophil extracellular trap mitigation in ischemic stroke outcomes. The research addresses vascular contributions to cognitive impairment and dementia following acute ischemic stroke by examining how neutrophils form extracellular...
- The National Institute of Neurological Disorders and Stroke awarded the University of Texas at Austin $393,284 on June 13, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct basic research on synaptic structural plasticity and stroke rehabilitation. The project examines how the brain remodels neural circuitry following stroke, with focus on reactive synaptogenesis—the growth of new connections among surviving neurons near...
- The National Institute of Neurological Disorders and Stroke awarded Florida International University $471,698 on May 13, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of perivascular fibroblasts in secondary spinal cord injury. The research focuses on peptidase inhibitor 16 (PI16) as a novel therapeutic target for neuroprotection after spinal cord injury. Preliminary studies indicate that activation of...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded $433,125 to the University of Texas Health Science Center at San Antonio on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of REST (Restrictive Element-1 Silencing Transcription Factor) in governing post-stroke neural plasticity and recovery. The...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded Wake Forest University $533,623 on September 3, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating mechanisms that protect neurons from glutamate excitotoxicity during metabolic stress. The research uses avian neurons, which naturally resist...